The development, assessment, and application of therapies for the prevention of cardiovascular disease complications, especially in the population of patients with type 2 diabetes mellitus.
RECENT PUBLICATIONS
Inzucchi SE, McGuire DK., "New Drugs for the Treatment of Diabetes: Incretin-based Therapy and Beyond" Circulation, 117:574-584, 2008
McGuire DK, Inzucchi SE, "New Drugs for the Treatment of Diabetes: Thiazolidinediones and their Evolving Cardiovascular Implications" Circulation, 117:440-449, 2008
Lindsey JB, de Lemos JA, Cipollone F, Ayers CR, Rohatgi A, Morrow DA, Khera A, McGuire DK., "Association Between Circulating Soluble Receptor for Advanced Glycation End Products (sRAGE) and Risk for Atherosclerosis: the Dallas Heart Study" Diabetes Care, 32:1218-1220, 2009
Morrow DA, Scirica BM, Chaitman BR, McGuire DK, Murphy SA, Karwatowska-Prokopczuk E, McCabe CH, Braunwald E, "Evaluation of the Glycometabolic Effects of Ranolazine in Patients With and Without Diabetes Mellitus in the MERLIN-TIMI 36 Randomized Controlled Trial." Circulation, 119:20032-20039, 2009
Point and right click (click and hold for Mac users) your mouse onand select "Save this link (or target) as..." option to save the file to your local computer.
and select "Save this link (or target) as..." option to save the file to your local computer.